CC
BMY icon

Centiva Capital’s Bristol-Myers Squibb BMY Stock Holding History

Centiva Capital’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.91M Buy
+64,500
New +$3.76M 0.03% 316
2024
Q2 		– Sell
-22,500
Closed -$1.22M – 2080
2024
Q1 		$1.22M Buy
22,500
+12,400
+123% +$632K 0.03% 562
2023
Q4 		$518K Sell
10,100
-7,500
-43% -$394K 0.01% 944
2023
Q3 		$1.02M Buy
17,600
+4,800
+38% +$294K 0.02% 632
2023
Q2 		$819K Sell
12,800
-42,900
-77% -$2.88M 0.02% 645
2023
Q1 		$3.86M Sell
55,700
-21,900
-28% -$1.54M 0.09% 235
2022
Q4 		$5.58M Sell
77,600
-85,000
-52% -$6.41M 0.16% 138
2022
Q3 		$11.6M Buy
162,600
+70,500
+77% +$5.11M 0.22% 49
2022
Q2 		$7.09M Buy
92,100
+55,100
+149% +$4.2M 0.17% 93
2022
Q1 		$2.7M Buy
37,000
+23,800
+180% +$1.6M 0.05% 337
2021
Q4 		$823K Buy
13,200
+11,880
+900% +$697K 0.02% 678
2021
Q3 		$78K Sell
1,320
-31,880
-96% -$2.1M ﹤0.01% 1087
2021
Q2 		$2.22M Buy
+33,200
New +$2.16M 0.05% 298
2020
Q1 		– Sell
-32,500
Closed -$2.08M – 637
2019
Q4 		$2.08M Buy
+32,500
New +$1.86M 0.1% 192
2019
Q1 		– Sell
-54,700
Closed -$2.84M – 319
2018
Q4 		$2.84M Buy
54,700
+39,600
+262% +$2.13M 0.22% 62
2018
Q3 		$937K Buy
+15,100
New +$896K 0.08% 105

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Centiva Capital's BMY Position: Q1 2026 in Review

Centiva Capital reduced its Bristol-Myers Squibb (BMY) stake by 33% in Q1 2026, selling an estimated $2.36M and leaving 81,733 shares worth $4.96M. The position accounts for 0.04% of the portfolio, ranked #280.

Centiva Capital first reported a position in BMY in Q3 2018 and has held it in 25 quarters since. The position peaked at $6.59M in Q4 2025. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Centiva Capital held 81,733 shares of Bristol-Myers Squibb worth $4.96M as of Q1 2026.
  • Centiva Capital sold 40,450 Bristol-Myers Squibb shares in Q1 2026, an estimated $2.36M.
  • Bristol-Myers Squibb made up 0.04% of Centiva Capital's portfolio in Q1 2026, its #280 holding.
  • Centiva Capital first reported a position in Bristol-Myers Squibb in Q3 2018 and has held it in 25 quarters since.
  • Centiva Capital's Bristol-Myers Squibb position peaked at $6.59M in Q4 2025.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Centiva Capital's 13F filing for Q1 2026, filed 14 May 2026.